Clinical Trials Browser

Phase 3 × Withdrawn × Olanzapine × Clear all

NCT05403580 2024-05-06

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Phase 3 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms